Etid klinik pou Psoryaz nan Kalifòni
14 etid pou Psoryaz ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, Fountain Valley
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07013201A Study to Assess Deucravacitinib Safety in Pregnancy
- University of California San Diego, La Jolla
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Fanm · Mizajou Oct 1, 2026 · NCT07017699Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Fremont
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07362017The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07487831A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- ak 1 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Local Institution - 0025, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Dermatology Research Associates, Los Angeles
- ak 3 plis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 3, 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50176, Fremont
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07219420The Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Liao Lab at UCSF, San Francisco
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07390487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Chula Vista
- Study Center, Fountain Valley
- Study Center, Fremont
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 9, 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- University of California, Davis - Dermatology Department, Sacramento
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT06574178A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- Bausch Site 2, Thousand Oaks
Ap rekriteFaz 4
Laj 6 a 17 · Tout sèks · Mizajou Aug 27, 2025 · NCT03987763Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Kinetic Clinical Research, Anaheim
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Aug 7, 2025 · NCT06846710Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jan 28, 2025 · NCT02103361Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.